NDC 63323-886
Sodium Phosphates
Sodium Phosphate, Monobasic, Monohydrate And Sodium Phosphate, Dibasic, Anhydrous
Sodium Phosphates is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate.
| Product ID | 63323-886_3ae3c9a3-3503-4264-8c77-00089f50cc74 |
| NDC | 63323-886 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sodium Phosphates |
| Generic Name | Sodium Phosphate, Monobasic, Monohydrate And Sodium Phosphate, Dibasic, Anhydrous |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-03-30 |
| Marketing Category | ANDA / |
| Application Number | ANDA209997 |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| Active Ingredient Strength | 142 mg/mL; mg/mL |
| Pharm Classes | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |